U.S. Biotech Stock News

NVIDIA (NasdaqGS:NVDA) has joined forces with AMD, Broadcom, Meta, Microsoft, and OpenAI to launch the Optical Compute Interconnect (OCI) Multi-Source Agreement. The OCI MSA focuses on standardizing optical interconnects for future AI hardware architectures in hyperscale data centers. This initiative targets a shift away from proprietary, copper-based connections toward interoperable, silicon centric optical links across multiple vendors. NVIDIA is widely known for its GPU platforms used in...

If you are wondering whether Chevron’s recent share price puts it at a premium or a bargain, this article walks through what the current valuation really suggests. Chevron shares last closed at US$196.82, with returns of 3.6% over the past 7 days, 5.9% over 30 days, 26.2% year to date, 31.0% over 1 year, 46.7% over 3 years and 134.5% over 5 years. These figures may influence how investors think about upside and risk today. Recent headlines around Chevron have focused on its position as a...

Earlier in March 2026, Jack Henry & Associates announced that its cloud-native Jack Henry Financial Crimes Defender platform was added to the Independent Community Bankers of America Preferred Service Provider program, underscoring its role in helping community banks detect fraud and support BSA/AML compliance on a unified, real-time analytics platform. This endorsement reinforces Jack Henry’s long-running ties with community banks and highlights how its AI-driven fraud and compliance tools...

If you are trying to figure out whether Stride's current share price reflects its real value, you are in the right place to break that question down in a practical way. Stride's shares last closed at US$84.36, with returns of a 2.8% decline over 7 days, a 1.8% decline over 30 days, a 30.6% gain year to date, a 30.5% decline over the past year, a 118.2% gain over 3 years and a 199.1% gain over 5 years. These mixed returns sit against a backdrop of ongoing interest in online and blended...

Earlier this week, PTC Therapeutics was lifted by a broader biotech upswing after the departure of an FDA official viewed as a hurdle to accelerated approvals in cell and gene therapies, prompting investors to reassess regulatory risk across the sector. The shift in FDA leadership has reduced perceived barriers for PTC’s gene and RNA-based pipeline, sharpening focus on how regulatory attitudes might influence its rare disease portfolio. We’ll now examine how this change in perceived FDA...

Centene Corporation recently presented at Barclays’ 28th Annual Global Healthcare Conference in Miami, where management reaffirmed 2026 earnings guidance and announced a partial redemption of US$1.00 billion of 4.25% notes due 2027. At the same time, the company reported a sharp drop in Affordable Care Act marketplace enrollment and rising specialty pharmacy utilization, highlighting pressure points within its core government-focused health plan portfolio. We’ll now explore how the steep ACA...

In late February 2026, Sysco Corporation’s Chief Financial Officer Kenny Cheung resigned to join a Fortune 10 company outside foodservice, with longtime internal finance leader Brandon Sewell appointed interim CFO from March 6 while Cheung stays on as an advisor until mid-April to support continuity. By reaffirming its fiscal 2026 earnings guidance alongside the CFO transition, Sysco signaled management’s confidence in its existing financial plans and execution framework despite the...

MillerKnoll stock snapshot MillerKnoll (MLKN) is back on investor radars after recent share price moves, with the stock now around $18.96 and mixed returns across the past week, month, and past 3 months. See our latest analysis for MillerKnoll. Recent moves in MillerKnoll’s share price tell a mixed story, with a 30 day share price return of a 16.73% decline, contrasting with a 90 day share price return of a 13.81% gain and a 1 year total shareholder return of 3.23%. This suggests momentum has...

Barbie x CCM partnership adds a fresh angle to Mattel’s investment story Mattel (MAT) and CCM Hockey have launched a Barbie x CCM Collection, a new line of hockey gear and apparel tied to inclusivity and self expression, introducing another way for the Barbie brand to reach sports focused consumers. See our latest analysis for Mattel. The Barbie x CCM launch lands while Mattel’s share price sits at US$16.06, with a 90 day share price return of 20.53% decline and a 1 year total shareholder...

In early March 2026, Sea Limited reported its fourth-quarter and full-year 2025 results, with revenue rising to US$6,851.87 million for the quarter and US$22.94 billion for the year, while net income increased to US$397.10 million and US$1.58 billion respectively, alongside completing a US$14.50 million share buyback of 116,200 shares announced in November 2025. The results highlight strong top-line and earnings growth across Shopee, SeaMoney, and Garena, but also reveal that heavier...

Why Ralph Lauren (RL) is on investors’ radar today Ralph Lauren (RL) is drawing fresh attention after its recent share performance, with the stock showing a negative move over the past week, month, and past 3 months even as its 1 year total return remains strongly positive. For investors, that mix of shorter term weakness and longer term strength raises questions about how the current price of about US$330.73 lines up with the company’s fundamentals, including annual revenue of US$7,833.1m...

In recent weeks, Republic Services reported strong Q4 2025 results and issued upbeat 2026 guidance, prompting several analysts to reiterate or initiate positive ratings while institutional investors increased their stakes in the waste management company. This combination of favorable analyst commentary, renewed institutional interest, and the company’s push into higher-margin recycling, environmental services, and sustainability initiatives highlights growing conviction in Republic Services’...

Regeneron Pharmaceuticals stock: context behind recent moves Regeneron Pharmaceuticals (REGN) shares have seen mixed returns recently, with a 1 day decline of about 0.1% and a 1 week decline near 1.9%, even as the past year shows positive total return. At a last close of US$745.77, Regeneron sits below its indicated intrinsic value estimate. The data here suggests an intrinsic discount of about 58%. That gap is central to how some investors may currently frame the stock. See our latest...

EVERTEC overview and recent performance snapshot EVERTEC (EVTC) has been drawing fresh attention after recent share price moves, with the stock up about 1% over the past day and roughly 3% over the past week. Over the past month the shares show a gain of about 12%, while the past 3 months reflect a small decline of around 1%. On a longer view, EVERTEC’s total return is negative over the past year, 3 years, and 5 years. See our latest analysis for EVERTEC. Short term momentum has picked up for...

Event context and recent share performance AGNC Investment (AGNC) has been drawing attention after a period of weaker recent returns, with the share price down 1.5% over the past day, 3.9% over the past week, and about 10.5% over the past month. See our latest analysis for AGNC Investment. Despite the weaker recent share price returns, with the latest close at $10.23 and a 30 day share price return decline of 10.5%, AGNC Investment’s longer term picture looks different, with a 1 year total...

Why Federal Agricultural Mortgage stock is drawing attention now Federal Agricultural Mortgage (AGM) has come onto investors’ radar after a period of weaker share performance, with the stock showing negative returns over the past month, past 3 months, year to date, and past year. Against that backdrop, some investors are reassessing the company’s valuation, given its reported US$372.34 million in revenue, US$182.493 million in net income, and a value score of 6. See our latest analysis for...

PEDEVCO (NYSEAM:PED) has expanded its board of directors and appointed Edward Geiser as a new director. Geiser will serve as Chairperson of the Nominating and Corporate Governance Committee. The company has also approved a 1 for 20 stock split, with implementation expected in the near term. PEDEVCO operates in the energy sector, where capital allocation, drilling decisions, and reservoir management are closely tied to governance quality. Adding an industry veteran like Edward Geiser to lead...

If you are wondering whether T. Rowe Price Group is quietly turning into a value opportunity, the starting point is to understand what the current share price implies about the business. The stock last closed at US$88.59, with returns of a 2.0% decline over the past week, a 5.5% decline over the last month, a 15.3% decline year to date, and a 1.1% decline over one year, while the three and five year returns stand at a 6.8% decline and a 36.2% decline respectively. Recent coverage has focused...

If you are looking at Mobileye Global and wondering whether the current share price lines up with its long term potential, you are not alone. The stock closed at US$7.57 most recently, after returns of a 5.5% decline over 7 days, a 21.4% decline over 30 days, a 32.6% decline year to date and a 49.4% decline over the past year, with an 82.6% decline over three years. Recent headlines around Mobileye have focused on its position in advanced driver assistance and autonomous driving technology,...

If you are wondering whether Kinder Morgan's current share price lines up with its underlying value, you are not alone. This article is built to help you frame that question clearly. Over shorter periods the stock has been mixed, with a 0.6% decline over the last 7 days, a 6.2% return over 30 days, and longer term returns of 20.5% year to date, 28.5% over 1 year, 140.5% over 3 years and 178.2% over 5 years. Recent attention on Kinder Morgan has focused on its position as a major North...

ICL Group snapshot and recent share performance ICL Group (NYSE:ICL) has been drawing attention after a mixed stretch for the share price, with gains over the past 3 months but declines over the month, year to date, and past year. For context, the stock last closed at US$5.37. Over the past 3 years it has delivered a negative total return, while the 5 year total return figure is positive. This gives you a sense of the different experiences recent and longer term shareholders have had. On the...

G-III Apparel Group (GIII) is back in focus after fourth quarter results and cautious fiscal 2027 guidance highlighted the financial hit from ending Calvin Klein and Tommy Hilfiger licenses, as well as exposure to the Saks bankruptcy. See our latest analysis for G-III Apparel Group. The weak fourth quarter, softer fiscal 2027 outlook and Saks-related charges have gone hand in hand with fading momentum, with a 30 day share price return of 12.5% and a 90 day share price return of 16.0%, while...

If you are looking at Fermi and wondering whether the recent share price gives you value or just extra risk, you are not alone. The stock last closed at US$7.96, with returns of a 0.6% decline over 7 days, a 16.4% decline over 30 days and a 9.8% decline year to date, which can change how investors think about its potential and its risk profile. Recent company updates and market commentary around Fermi have kept attention on how its fundamentals line up with its share price, and that is where...

Wondering if General Motors at around US$72.39 is still offering value after its strong run, or if most of the upside is already baked in? This article is built to help you frame that question clearly. The stock has seen a 51.3% return over the past year and a 123.8% return over the past three years, even though the past month has brought a 9.3% pullback and a 10.6% decline year to date. Recent headlines around General Motors have focused on the company’s position in the US auto market,...